Skip to main content
SLNO logo

SLNO · Soleno Therapeutics Inc

$53.01 +0.00 (+0.00%) At close · May 18
Market Cap
$2.76B
Shares
52.12M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2025-08-15 Abingworth Bioventures VII LP 1,347,522
2025-07-01 PATRICIA HIRANO 3,830
2025-06-24 PATRICIA HIRANO 266
2025-04-01 PATRICIA HIRANO 3,782
2025-03-28 PATRICIA HIRANO 27,662
2025-03-28 Matthew Pauls 5,937
2025-03-27 PATRICIA HIRANO 111,124
2025-03-27 Patricia C Hirano 23,375
2025-03-27 Michael F. Huang 29,625
2025-03-27 Bhatnagar Anish 746,041
2025-03-27 James H Mackaness 92,500
2025-03-27 Kristen Yen 97,006
2025-03-27 Meredith Manning 48,000
2024-10-21 Abingworth Bioventures VII LP 949,336
2024-10-07 Abingworth Bioventures VII LP 2,522,751
2024-06-28 Melincoff Gwen A 12,666
2023-12-14 Hirano Patricia C 1,359
2023-12-13 Hirano Patricia C 4,885
2023-12-13 Yen Kristen 17,916
2023-12-12 Yen Kristen 19,913
2023-12-11 Anish Bhatnagar 93,408
2023-12-11 Mackaness James H 32,482
Showing 1–22 of 22 filings
Key facts CIK 1484565 CUSIP 834203309 Visit website Investor relations